Actively Recruiting
Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Led by University Health Network, Toronto · Updated on 2026-03-30
1000
Participants Needed
1
Research Sites
363 weeks
Total Duration
On this page
Sponsors
U
University Health Network, Toronto
Lead Sponsor
A
Avicanna Inc
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.
CONDITIONS
Official Title
Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
- Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
- Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study
You will not qualify if you...
- Concomitant use of illicit drugs
- Concomitant use of recreational cannabis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Toronto General Hospital, UHN
Toronto, Ontario, Canada, M5G 2C4
Actively Recruiting
Research Team
S
Sonal Thaker
CONTACT
J
Jo Carroll, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here